{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T21:56:24Z","timestamp":1767995784001,"version":"3.49.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2010,11,23]],"date-time":"2010-11-23T00:00:00Z","timestamp":1290470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/2.0"},{"start":{"date-parts":[[2010,11,23]],"date-time":"2010-11-23T00:00:00Z","timestamp":1290470400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2010,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Dll4\/Notch and Ephrin-B2\/EphB4 pathways play critical roles in tumor vessel development and maturation. This study evaluates the efficacy of the inhibition of both signaling pathways, alone and in combination, in reducing the growth of an autochthonous mouse tumor and assesses potential adverse effects.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>We used the transgenic RIP1-Tag2 tumor model to study the effects of 1) inhibition of Dll4\/Notch by either <jats:italic>Dll4<\/jats:italic> allelic deletion or use of a soluble extracellular Dll4 (sDll4), 2) inhibition of Ephrin-B2\/EphB4 signaling by a soluble extracellular EphB4 fused to albumin (sEphB4-Alb), and 3) inhibition of both pathways by sEphB4-Alb combined with either <jats:italic>Dll4<\/jats:italic> allelic deletion or sDll4. To investigate adverse effects, we used inducible endothelial-specific <jats:italic>Dll4<\/jats:italic> knock-out mice, treated with sEphB4-Alb, and carried out histopathological analysis.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>\n              <jats:italic>Dll4<\/jats:italic> allele deletion or soluble Dll4 treatment resulted in increased tumor vessel density, reduced mural cell recruitment and vessel perfusion which resulted in reduced tumor size. The soluble EphB4 instead reduced vessel density and vessel perfusion, leading to reduction of tumor size. Greater efficacy was observed when sEphB4-Alb was combined with either <jats:italic>Dll4<\/jats:italic> allele deletion or sDll4 in regards to tumor size, vessel perfusion and mural cell recruitment. Induced endothelial specific <jats:italic>Dll4<\/jats:italic> loss-of-function caused hepatic vascular alterations, which were prevented by concomitant sEphB4-Alb treatment.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>Combination targeting of Dll4\/Notch and Ephrin-B2\/EphB4 has potential for clinical investigation, providing cumulative efficacy and increased safety over Dll4\/Notch inhibition alone.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1471-2407-10-641","type":"journal-article","created":{"date-parts":[[2010,11,23]],"date-time":"2010-11-23T19:15:54Z","timestamp":1290539754000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":73,"title":["Combination of Dll4\/Notch and Ephrin-B2\/EphB4 targeted therapy is highly effective in disrupting tumor angiogenesis"],"prefix":"10.1186","volume":"10","author":[{"given":"Dusan","family":"Djokovic","sequence":"first","affiliation":[]},{"given":"Alexandre","family":"Trindade","sequence":"additional","affiliation":[]},{"given":"Joana","family":"Gigante","sequence":"additional","affiliation":[]},{"given":"Marina","family":"Badenes","sequence":"additional","affiliation":[]},{"given":"Lilliana","family":"Silva","sequence":"additional","affiliation":[]},{"given":"Ren","family":"Liu","sequence":"additional","affiliation":[]},{"given":"Xiuqing","family":"Li","sequence":"additional","affiliation":[]},{"given":"Ming","family":"Gong","sequence":"additional","affiliation":[]},{"given":"Valery","family":"Krasnoperov","sequence":"additional","affiliation":[]},{"given":"Parkash S","family":"Gill","sequence":"additional","affiliation":[]},{"given":"Antonio","family":"Duarte","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2010,11,23]]},"reference":[{"issue":"1","key":"2440_CR1","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1111\/j.1538-7836.2008.03203.x","volume":"7","author":"S Loges","year":"2009","unstructured":"Loges S, Roncal C, Carmeliet P: Development of targeted angiogenic medicine. J Thromb Haemost. 2009, 7 (1): 21-33. 10.1111\/j.1538-7836.2008.03203.x.","journal-title":"J Thromb Haemost"},{"issue":"8","key":"2440_CR2","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1038\/nrc2442","volume":"8","author":"G Bergers","year":"2008","unstructured":"Bergers G, Hanahan D: Modes of resistance to anti-angiogenic therapy. Nat Rev Cancer. 2008, 8 (8): 592-603. 10.1038\/nrc2442.","journal-title":"Nat Rev Cancer"},{"issue":"45","key":"2440_CR3","doi-asserted-by":"publisher","first-page":"15949","DOI":"10.1073\/pnas.0407290101","volume":"101","author":"NW Gale","year":"2004","unstructured":"Gale NW, Dominguez MG, Noguera I, Pan L, Hughes V, Valenzuela DM, Murphy AJ, Adams NC, Lin HC, Holash J, Thurston G, Yancopoulos GD: Haploinsufficiency of delta-like 4 ligand results in embryonic lethality due to major defects in arterial and vascular development. Proc Natl Acad Sci USA. 2004, 101 (45): 15949-54. 10.1073\/pnas.0407290101.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"20","key":"2440_CR4","doi-asserted-by":"publisher","first-page":"2474","DOI":"10.1101\/gad.1239004","volume":"18","author":"A Duarte","year":"2004","unstructured":"Duarte A, Hirashima M, Benedito R, Trindade A, Diniz P, Bekman E, Costa L, Henrique D, Rossant J: Dosage-sensitive requirement for mouse Dll4 in artery development. Genes Dev. 2004, 18 (20): 2474-8. 10.1101\/gad.1239004.","journal-title":"Genes Dev"},{"issue":"19","key":"2440_CR5","doi-asserted-by":"publisher","first-page":"8690","DOI":"10.1158\/0008-5472.CAN-05-1208","volume":"65","author":"NS Patel","year":"2005","unstructured":"Patel NS, Li JL, Generali D, Poulsom R, Cranston DW, Harris AL: Up-regulation of delta-like 4 ligand in human tumor vasculature and the role of basal expression in endothelial cell function. Cancer Res. 2005, 65 (19): 8690-7. 10.1158\/0008-5472.CAN-05-1208.","journal-title":"Cancer Res"},{"issue":"2-3","key":"2440_CR6","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1046\/j.1432-0436.2001.690207.x","volume":"69","author":"C Mailhos","year":"2001","unstructured":"Mailhos C, Modlich U, Lewis J, Harris A, Bicknell R, Ish-Horowicz D: Delta4, an endothelial specific notch ligand expressed at sites of physiological and tumor angiogenesis. Differentiation. 2001, 69 (2-3): 135-44. 10.1046\/j.1432-0436.2001.690207.x.","journal-title":"Differentiation"},{"issue":"7122","key":"2440_CR7","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1038\/nature05355","volume":"444","author":"I Noguera-Troise","year":"2006","unstructured":"Noguera-Troise I, Daly C, Papadopoulos NJ, Coetzee S, Boland P, Gale NW, Lin HC, Yancopoulos GD, Thurston G: Blockade of Dll4 inhibits tumour growth by promoting non-productive angiogenesis. Nature. 2006, 444 (7122): 1032-7. 10.1038\/nature05355.","journal-title":"Nature"},{"issue":"11","key":"2440_CR8","doi-asserted-by":"publisher","first-page":"4753","DOI":"10.1182\/blood-2006-12-063933","volume":"109","author":"JS Scehnet","year":"2007","unstructured":"Scehnet JS, Jiang W, Kumar SR, Krasnoperov V, Trindade A, Benedito R, Djokovic D, Borges C, Ley EJ, Duarte A, Gill PS: Inhibition of Dll4-mediated signaling induces proliferation of immature vessels and results in poor tissue perfusion. Blood. 2007, 109 (11): 4753-60. 10.1182\/blood-2006-12-063933.","journal-title":"Blood"},{"issue":"3","key":"2440_CR9","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1182\/blood-2005-03-1000","volume":"107","author":"CK Williams","year":"2006","unstructured":"Williams CK, Li JL, Murga M, Harris AL, Tosato G: Up-regulation of the Notch ligand Delta-like 4 inhibits VEGF-induced endothelial cell function. Blood. 2006, 107 (3): 931-9. 10.1182\/blood-2005-03-1000.","journal-title":"Blood"},{"issue":"9","key":"2440_CR10","doi-asserted-by":"publisher","first-page":"3219","DOI":"10.1073\/pnas.0611206104","volume":"104","author":"IB Lobov","year":"2007","unstructured":"Lobov IB, Renard RA, Papadopoulos N, Gale NW, Thurston G, Yancopoulos GD, Wiegand SJ: Delta-like ligand 4 (Dll4) is induced by VEGF as a negative regulator of angiogenic sprouting. Proc Natl Acad Sci USA. 2007, 104 (9): 3219-24. 10.1073\/pnas.0611206104.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"9","key":"2440_CR11","doi-asserted-by":"publisher","first-page":"3225","DOI":"10.1073\/pnas.0611177104","volume":"104","author":"S Suchting","year":"2007","unstructured":"Suchting S, Freitas C, le Noble F, Benedito R, Breant C, Duarte A, Eichmann A: The Notch ligand Delta-like 4 negatively regulates endothelial tip cell formation and vessel branching. Proc Natl Acad Sci USA. 2007, 104 (9): 3225-30. 10.1073\/pnas.0611177104.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"7122","key":"2440_CR12","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1038\/nature05313","volume":"444","author":"J Ridgway","year":"2006","unstructured":"Ridgway J, Zhang G, Wu Y, Stawicki S, Liang WC, Chanthery Y, Kowalski J, Watts RJ, Callahan C, Kasman I, Singh M, Chien M, Tan C, Hongo JA, de Sauvage F, Plowman G, Yan M: Inhibition of Dll4 signalling inhibits tumour growth by deregulating angiogenesis. Nature. 2006, 444 (7122): 1083-7. 10.1038\/nature05313.","journal-title":"Nature"},{"issue":"6","key":"2440_CR13","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1242\/dev.129.6.1397","volume":"129","author":"SS Gerety","year":"2002","unstructured":"Gerety SS, Anderson DJ: Cardiovascular ephrinB2 function is essential for embryonic angiogenesis. Development. 2002, 129 (6): 1397-1410.","journal-title":"Development"},{"issue":"3","key":"2440_CR14","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1101\/gad.13.3.295","volume":"13","author":"RH Adams","year":"1999","unstructured":"Adams RH, Wilkinson GA, Weiss C, Diella F, Gale NW, Deutsch U, Risau W, Klein R: Roles of ephrinB ligands and EphB receptors in cardiovascular development: demarcation of arterial\/venous domains, vascular morphogenesis, and sprouting angiogenesis. Genes Dev. 1999, 13 (3): 295-306. 10.1101\/gad.13.3.295.","journal-title":"Genes Dev"},{"issue":"3","key":"2440_CR15","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/S1097-2765(00)80342-1","volume":"4","author":"SS Gerety","year":"1999","unstructured":"Gerety SS, Wang HU, Chen ZF, Anderson DJ: Symmetrical mutant phenotypes of the receptor EphB4 and its specific transmembrane ligand ephrin-B2 in cardiovascular development. Mol Cell. 1999, 4 (3): 403-414. 10.1016\/S1097-2765(00)80342-1.","journal-title":"Mol Cell"},{"issue":"6","key":"2440_CR16","doi-asserted-by":"publisher","first-page":"2330","DOI":"10.1182\/blood-2005-04-1655","volume":"107","author":"N Kertesz","year":"2006","unstructured":"Kertesz N, Krasnoperov V, Reddy R, Leshanski L, Kumar SR, Zozulya S, Gill PS: The soluble extracellular domain of EphB4 (sEphB4) antagonizes EphB4-EphrinB2 interaction, modulates angiogenesis, and inhibits tumor growth. Blood. 2006, 107 (6): 2330-2338. 10.1182\/blood-2005-04-1655.","journal-title":"Blood"},{"issue":"1","key":"2440_CR17","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1182\/blood-2008-02-140020","volume":"113","author":"JS Scehnet","year":"2009","unstructured":"Scehnet JS, Ley EJ, Krasnoperov V, Liu R, Manchanda PK, Sjoberg E, Kostecke AP, Gupta S, Kumar SR, Gill PS: The role of Ephs, Ephrins, and growth factors in Kaposi sarcoma and implications of EphrinB2 blockade. Blood. 2009, 113 (1): 254-263. 10.1182\/blood-2008-02-140020.","journal-title":"Blood"},{"issue":"6015","key":"2440_CR18","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1038\/315115a0","volume":"315","author":"D Hanahan","year":"1985","unstructured":"Hanahan D: Heritable formation of pancreatic beta-cell tumours in transgenic mice expressing recombinant insulin\/simian virus 40 oncogenes. Nature. 1985, 315 (6015): 115-122. 10.1038\/315115a0.","journal-title":"Nature"},{"issue":"5415","key":"2440_CR19","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1126\/science.284.5415.808","volume":"284","author":"G Bergers","year":"1999","unstructured":"Bergers G, Javaherian K, Lo KM, Folkman J, Hanahan D: Effects of angiogenesis inhibitors on multistage carcinogenesis in mice. Science. 1999, 284 (5415): 808-812. 10.1126\/science.284.5415.808.","journal-title":"Science"},{"issue":"7282","key":"2440_CR20","doi-asserted-by":"publisher","first-page":"E6","DOI":"10.1038\/nature08751","volume":"463","author":"M Yan","year":"2010","unstructured":"Yan M, Callahan CA, Beyer JC, Allamneni KP, Zhang G, Ridgway JB, Niessen K, Plowman GD: Chronic DLL4 blockade induces vascular neoplasms. Nature. 2010, 463 (7282): E6-7. 10.1038\/nature08751.","journal-title":"Nature"},{"issue":"4","key":"2440_CR21","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1182\/blood-2009-08-236745","volume":"115","author":"R Liu","year":"2010","unstructured":"Liu R, Li X, Tulpule A, Zhou Y, Scehnet JS, Zhang S, Lee JS, Chaudhary PM, Jung J, Gill PS: KSHV-induced notch components render endothelial and mural cell characteristics and cell survival. Blood. 2010, 115 (4): 887-895. 10.1182\/blood-2009-08-236745.","journal-title":"Blood"},{"issue":"15","key":"2440_CR22","doi-asserted-by":"publisher","first-page":"3631","DOI":"10.1182\/blood-2008-07-170381","volume":"113","author":"S Yamanda","year":"2009","unstructured":"Yamanda S, Ebihara S, Asada M, Okazaki T, Niu K, Ebihara T, Koyanagi A, Yamaguchi N, Yagita H, Arai H: Role of ephrinB2 in nonproductive angiogenesis induced by Delta-like 4 blockade. Blood. 2009, 113 (15): 3631-3639. 10.1182\/blood-2008-07-170381.","journal-title":"Blood"},{"issue":"3","key":"2440_CR23","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1016\/j.bbrc.2006.01.020","volume":"341","author":"T Iso","year":"2006","unstructured":"Iso T, Maeno T, Oike Y, Yamazaki M, Doi H, Arai M, Kurabayashi M: Dll4-selective Notch signaling induces ephrinB2 gene expression in endothelial cells. Biochem Biophys Res Commun. 2006, 341 (3): 708-14. 10.1016\/j.bbrc.2006.01.020.","journal-title":"Biochem Biophys Res Commun"},{"issue":"17","key":"2440_CR24","doi-asserted-by":"publisher","first-page":"8501","DOI":"10.1158\/0008-5472.CAN-05-4226","volume":"66","author":"P Hainaud","year":"2006","unstructured":"Hainaud P, Contreres JO, Villemain A, Liu LX, Plouet J, Tobelem G, Dupuy E: The role of the vascular endothelial growth factor-Delta-like 4 ligand\/Notch4-ephrin B2 cascade in tumor vessel remodeling and endothelial cell functions. Cancer Res. 2006, 66 (17): 8501-10. 10.1158\/0008-5472.CAN-05-4226.","journal-title":"Cancer Res"},{"issue":"7297","key":"2440_CR25","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1038\/nature08995","volume":"465","author":"S Sawamiphak","year":"2010","unstructured":"Sawamiphak S, Seidel S, Essmann CL, Wilkinson GA, Pitulescu ME, Acker T, Acker-Palmer A: Ephrin-B2 regulates VEGFR2 function in developmental and tumour angiogenesis. Nature. 2010, 465 (7297): 487-491. 10.1038\/nature08995.","journal-title":"Nature"},{"issue":"7297","key":"2440_CR26","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1038\/nature09002","volume":"465","author":"Y Wang","year":"2010","unstructured":"Wang Y, Nakayama M, Pitulescu ME, Schmidt TS, Bochenek ML, Sakakibara A, Adams S, Davy A, Deutsch U, Luthi U, Barberis A, Benjamin LE, Makinen T, Nobes CD, Adams RH: Ephrin-B2 controls VEGF-induced angiogenesis and lymphangiogenesis. Nature. 2010, 465 (7297): 483-486. 10.1038\/nature09002.","journal-title":"Nature"},{"issue":"3","key":"2440_CR27","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.conb.2004.05.010","volume":"14","author":"T Iwatsubo","year":"2004","unstructured":"Iwatsubo T: The gamma-secretase complex: machinery for intramembrane proteolysis. Curr Opin Neurobiol. 2004, 14 (3): 379-383. 10.1016\/j.conb.2004.05.010.","journal-title":"Curr Opin Neurobiol"},{"key":"2440_CR28","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1146\/annurev.neuro.26.041002.131334","volume":"26","author":"D Selkoe","year":"2003","unstructured":"Selkoe D, Kopan R: Notch and Presenilin: regulated intramembrane proteolysis links development and degeneration. Annu Rev Neurosci. 2003, 26: 565-597. 10.1146\/annurev.neuro.26.041002.131334.","journal-title":"Annu Rev Neurosci"},{"issue":"22","key":"2440_CR29","doi-asserted-by":"publisher","first-page":"2730","DOI":"10.1101\/gad.308904","volume":"18","author":"V Domenga","year":"2004","unstructured":"Domenga V, Fardoux P, Lacombe P, Monet M, Maciazek J, Krebs LT, Klonjkowski B, Berrou E, Mericskay M, Li Z, Tournier-Lasserve E, Gridley T, Joutel A: Notch3 is required for arterial identity and maturation of vascular smooth muscle cells. Genes Dev. 2004, 18 (22): 2730-2735. 10.1101\/gad.308904.","journal-title":"Genes Dev"},{"issue":"4","key":"2440_CR30","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1161\/CIRCRESAHA.108.184846","volume":"104","author":"H Liu","year":"2009","unstructured":"Liu H, Kennard S, Lilly B: NOTCH3 expression is induced in mural cells through an autoregulatory loop that requires endothelial-expressed JAGGED1. Circ Res. 2009, 104 (4): 466-475. 10.1161\/CIRCRESAHA.108.184846.","journal-title":"Circ Res"},{"issue":"6","key":"2440_CR31","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1161\/01.RES.0000182903.16652.d7","volume":"97","author":"A Armulik","year":"2005","unstructured":"Armulik A, Abramsson A, Betsholtz C: Endothelial\/pericyte interactions. Circ Res. 2005, 97 (6): 512-523. 10.1161\/01.RES.0000182903.16652.d7.","journal-title":"Circ Res"},{"issue":"9","key":"2440_CR32","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1172\/JCI200317929","volume":"111","author":"G Bergers","year":"2003","unstructured":"Bergers G, Song S, Meyer-Morse N, Bergsland E, Hanahan D: Benefits of targeting both pericytes and endothelial cells in the tumor vasculature with kinase inhibitors. J Clin Invest. 2003, 111 (9): 1287-1295.","journal-title":"J Clin Invest"},{"issue":"8","key":"2440_CR33","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1172\/JCI200318549","volume":"112","author":"A Abramsson","year":"2003","unstructured":"Abramsson A, Lindblom P, Betsholtz C: Endothelial and nonendothelial sources of PDGF-B regulate pericyte recruitment and influence vascular pattern formation in tumors. J Clin Invest. 2003, 112 (8): 1142-1151.","journal-title":"J Clin Invest"},{"issue":"4","key":"2440_CR34","first-page":"1464","volume":"61","author":"RM Shaheen","year":"2001","unstructured":"Shaheen RM, Tseng WW, Davis DW, Liu W, Reinmuth N, Vellagas R, Wieczorek AA, Ogura Y, McConkey DJ, Drazan KE, Bucana CD, McMahon G, Ellis LM: Tyrosine kinase inhibition of multiple angiogenic growth factor receptors improves survival in mice bearing colon cancer liver metastases by inhibition of endothelial cell survival mechanisms. Cancer Res. 2001, 61 (4): 1464-1468.","journal-title":"Cancer Res"},{"key":"2440_CR35","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1210\/rp.59.1.51","volume":"59","author":"KG Peters","year":"2004","unstructured":"Peters KG, Kontos CD, Lin PC, Wong AL, Rao P, Huang L, Dewhirst MW, Sankar S: Functional significance of Tie2 signaling in the adult vasculature. Recent Prog Horm Res. 2004, 59: 51-71. 10.1210\/rp.59.1.51.","journal-title":"Recent Prog Horm Res"},{"issue":"6535","key":"2440_CR36","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1038\/376070a0","volume":"376","author":"TN Sato","year":"1995","unstructured":"Sato TN, Tozawa Y, Deutsch U, Wolburg-Buchholz K, Fujiwara Y, Gendron-Maguire M, Gridley T, Wolburg H, Risau W, Qin Y: Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formation. Nature. 1995, 376 (6535): 70-74. 10.1038\/376070a0.","journal-title":"Nature"},{"issue":"1","key":"2440_CR37","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.cell.2005.10.034","volume":"124","author":"SS Foo","year":"2006","unstructured":"Foo SS, Turner CJ, Adams S, Compagni A, Aubyn D, Kogata N, Lindblom P, Shani M, Zicha D, Adams RH: Ephrin-B2 controls cell motility and adhesion during blood-vessel-wall assembly. Cell. 2006, 124 (1): 161-173. 10.1016\/j.cell.2005.10.034.","journal-title":"Cell"},{"issue":"7193","key":"2440_CR38","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1038\/nature06868","volume":"453","author":"J Hamzah","year":"2008","unstructured":"Hamzah J, Jugold M, Kiessling F, Rigby P, Manzur M, Marti HH, Rabie T, Kaden S, Grone HJ, Hammerling GJ, Arnold B, Ganss R: Vascular normalization in Rgs5-deficient tumours promotes immune destruction. Nature. 2008, 453 (7193): 410-414. 10.1038\/nature06868.","journal-title":"Nature"},{"issue":"35","key":"2440_CR39","doi-asserted-by":"publisher","first-page":"23436","DOI":"10.1074\/jbc.M109.032664","volume":"284","author":"Y Jin","year":"2009","unstructured":"Jin Y, An X, Ye Z, Cully B, Wu J, Li J: RGS5, a hypoxia-inducible apoptotic stimulator in endothelial cells. J Biol Chem. 2009, 284 (35): 23436-23443. 10.1074\/jbc.M109.032664.","journal-title":"J Biol Chem"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-10-641.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/1471-2407-10-641\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-10-641","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-10-641.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T06:09:00Z","timestamp":1630476540000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/1471-2407-10-641"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,11,23]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["2440"],"URL":"https:\/\/doi.org\/10.1186\/1471-2407-10-641","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,11,23]]},"assertion":[{"value":"9 July 2010","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 November 2010","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 November 2010","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"641"}}